Antimicrobial resistance in hospitalized surgical patients: a silently emerging public health concern in Uganda

Springer Science and Business Media LLC - Tập 6 - Trang 1-7 - 2013
Jeremiah Seni1,2, Christine F Najjuka1, David P Kateete1, Patson Makobore3, Moses L Joloba1, Henry Kajumbula1, Antony Kapesa4, Freddie Bwanga1
1Department of Medical Microbiology, Makerere University College of Health Sciences, Kampala, Uganda
2Department of Microbiology and Immunology, Catholic University of Health and Allied Sciences-Bugando, Mwanza, Tanzania
3Department of Surgery, Makerere University College of Health Sciences, Kampala, Uganda
4Department of Community Medicine, Catholic University of Health and Allied Sciences-Bugando, Mwanza, Tanzania

Tóm tắt

Surgical site infections (SSIs) are difficult to treat and are associated with substantially longer hospital stay, higher treatment cost, morbidity and mortality, particularly when the etiological agent is multidrug-resistant (MDR). To address the limited data in Uganda on SSIs, we present the spectrum of bacteria isolated from hospitalized patients, the magnitude and impact of MDR bacterial isolates among patients with SSIs. A descriptive cross sectional study was conducted from September 2011 through April 2012 involving 314 patients with SSIs in the obstetrics & gynecology, general surgery and orthopedic wards at Mulago National Hospital in Kampala, Uganda. Wound swabs were taken and processed using standard microbiological methods. Clinico-demographic characteristics of patients were obtained using structured questionnaires and patients’ files. Of the 314 enrolled patients with SSIs (mean age 29.7 ±13.14 years), 239 (76.1%) were female. More than half of the patients were from obstetrics and gynecology (62.1%, 195/314). Of 314 wound swabs taken, 68.8% (216/314) were culture positive aerobically, yielding 304 bacterial isolates; of which 23.7% (72/304) were Escherichia coli and 21.1% (64/304) were Staphylococcus aureus. More than three quarters of Enterobacteriaceae were found to be extended spectrum beta lactamase (ESBL) producers and 37.5% of S. aureus were Methicillin resistant S. aureus (MRSA). MDR occurred in 78.3% (238/304) of the isolates; these were more among Gram-negative bacteria (78.6%, 187/238) compared to Gram-positive bacteria (21.4%, 51/238), (p-value < 0.0001, χ2 = 49.219). Amikacin and imepenem for ESBL-producing Enterobacteriacea and vancomycin for MRSA showed excellent performance except that they remain expensive drugs in Uganda. Most SSIs at Mulago National Hospital are due to MDR bacteria. Isolation of MRSA and ESBL-producing Enterobacteriaceae in higher proportions than previously reported calls for laboratory guided SSIs- therapy and strengthening of infection control surveillance in this setting.

Tài liệu tham khảo

Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG: CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control. 1992, 20 (5): 271-274. 10.1016/S0196-6553(05)80201-9.

Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR: Guideline for prevention of surgical site infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1999, 27 (2): 97-132. 10.1016/S0196-6553(99)70088-X. quiz 133–134; discussion 196

Emori TG, Gaynes RP: An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev. 1993, 6 (4): 428-442.

Fabiano G, Pezzolla A, Filograna MA, Ferrarese F: [Risk factors of surgical wound infection]. Ann Ital Chir. 2004, 75 (1): 11-16.

Astagneau P, Rioux C, Golliot F, Brucker G: Morbidity and mortality associated with surgical site infections: results from the 1997–1999 INCISO surveillance. J Hosp Infect. 2001, 48 (4): 267-274. 10.1053/jhin.2001.1003.

Barwolff S, Sohr D, Geffers C, Brandt C, Vonberg RP, Halle H, Ruden H, Gastmeier P: Reduction of surgical site infections after Caesarean delivery using surveillance. J Hosp Infect. 2006, 64 (2): 156-161. 10.1016/j.jhin.2006.06.009.

Santos KR, Fonseca LS, Bravo Neto GP, Gontijo Filho PP: Surgical site infection: rates, etiology and resistance patterns to antimicrobials among strains isolated at Rio de Janeiro University Hospital. Infection. 1997, 25 (4): 217-220. 10.1007/BF01713147.

Mawalla B, Mshana SE, Chalya PL, Imirzalioglu C, Mahalu W: Predictors of surgical site infections among patients undergoing major surgery at Bugando Medical Centre in Northwestern Tanzania. BMC Surgery. 2011, 11: 21-10.1186/1471-2482-11-21.

Anguzu JR, Olila D: Drug sensitivity patterns of bacterial isolates from septic post-operative wounds in a regional referral hospital in Uganda. Afr Health Sci. 2007, 7 (3): 148-154.

Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ: The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol. 2002, 23 (4): 183-189. 10.1086/502033.

Fehr J, Hatz C, Soka I, Kibatala P, Urassa H, Smith T, Mshinda H, Frei R, Widmer A: Risk factors for surgical site infection in a Tanzanian district hospital: a challenge for the traditional National Nosocomial Infections Surveillance system index. Infect Control Hosp Epidemiol. 2006, 27 (12): 1401-1404. 10.1086/509855.

Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ: The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999, 20 (11): 725-730. 10.1086/501572.

Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, Briggs JP, Sexton DJ, Kaye KS: Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003, 36 (5): 592-598. 10.1086/367653.

Wassef MA, Hussein A, Abdul Rahman EM, El-Sherif RH: A prospective surveillance of surgical site infections: study for efficacy of preoperative antibiotic prophylaxis. African Journal of Microbiology Research. 2012, 6 (12): 3072-3078.

Amare B, Abdurrahman Z, Moges B, Ali J, Muluken L, Alemayehu M, Yifru S, Sendek B, Belyhun YFM: Postoperative surgical site bacterial infections and drug susceptibility patterns at Gondar University Teaching Hospital, Northwest Ethiopia. J Bacteriol Parasitol. 2011, 2: 126-

Throckmorton AD, Baddour LM, Hoskin TL, Boughey JC, Degnim AC: Microbiology of surgical site infections complicating breast surgery. Surg Infect (Larchmt). 2010, 11 (4): 355-359. 10.1089/sur.2009.029.

Hawser SP, Bouchillon SK, Hoban DJ, Badal RE: Epidemiologic trends, occurrence of extended-spectrum beta-lactamase production, and performance of ertapenem and comparators in patients with intra-abdominal infections: analysis of global trend data from 2002–2007 from the SMART study. Surg Infect (Larchmt). 2010, 11 (4): 371-378. 10.1089/sur.2009.057.

Kownhar H, Shankar EM, Vignesh R, Sekar R, Velu V, Rao UA: High isolation rate of Staphylococcus aureus from surgical site infections in an Indian hospital. J Antimicrob Chemother. 2008, 61 (3): 758-760. 10.1093/jac/dkm519.

Krukerink M, Kievit J, de Mheen PJ M-v: Evaluation of routinely reported surgical site infections against microbiological culture results: a tool to identify patient groups where diagnosis and treatment may be improved. BMC Infect Dis. 2009, 9: 176-10.1186/1471-2334-9-176.

Olaro C: Study to assess the risk factors for postoperative complications following abdominal surgery in Mulago Hospital. 1999, Kampala: Makerere University

Ojulong J, Mwambu TP, Joloba M, Bwanga F, Kaddu-Mulindwa DH: Relative prevalence of methicilline resistant Staphylococcus aureus and its susceptibility pattern in Mulago Hospital, Kampala, Uganda. Tanzan J Health Res. 2009, 11 (3): 149-153.

Kitara DL, Kakande I, Mugisa BD, Obol JH: The postoperative complications prediction in Mulago Hospital using POSSUM scoring system. East and Central African Journal of Surgery. 2010, 15 (2): 90-96.

Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC: Color atlas and textbook of diagnostic microbiology.  . 1997, Philadelphia, Pa: Lippincott, Williams & Wilkins Publishers, 5

CLSI: Perfomance standars for antimicrobial susceptibility testing; twenty first information supplement, vol. CLSI document M100-S21. 2011, Wayne, PA: Clinical and Laboratory Standards Institute

Livermore DM, Brown DF: Detection of beta-lactamase-mediated resistance. J Antimicrob Chemother. 2001, 48 (Suppl 1): 59-64. 10.1093/jac/48.suppl_1.59.

D'Agata EM: Rapidly rising prevalence of nosocomial multidrug-resistant, F-negative bacilli: a 9-year surveillance study. Infect Control Hosp Epidemiol. 2004, 25 (10): 842-846. 10.1086/502306.

Razavi SM, Ibrahimpoor M, Sabouri Kashani A, Jafarian A: Abdominal surgical site infections: incidence and risk factors at an Iranian teaching hospital. BMC Surg. 2005, 5: 2-10.1186/1471-2482-5-2.

Kasatpibal N, Jamulitrat S, Chongsuvivatwong V: Standardized incidence rates of surgical site infection: a multicenter study in Thailand. Am J Infect Control. 2005, 33 (10): 587-594. 10.1016/j.ajic.2004.11.012.

Wenzel RP, Perl TM: The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect. 1995, 31 (1): 13-24. 10.1016/0195-6701(95)90079-9.

Atata RF, Ibrahim YKE, Olurinola PF, Giwa A, Akanbi AA, Sani AA: Clinical bacterial isolates from hospital environment as agents of surgical wound nosocomial infections. Journal of Pharmacy & Bioresources. 2010, 7 (2): 146-155.

Adegoke AA, Mvuyo T, Okoh AI, Steve J: Studies on multiple antibiotic resistant bacterial isolated from surgical site infection. Scientific Research and Essays. 2010, 5 (24): 3876-3881.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 6

1-7

Thông tin tác giả